Free Trial
→ My public warning after 55 years of watching the markets (From Weiss Ratings) (Ad)tc pixel
NASDAQ:NYXH

Nyxoah Q4 2025 Earnings Results & Report

Nyxoah logo
$0.90 0.00 (-0.11%)
As of 11:15 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Nyxoah reported Q4 2025 earnings on February 14, 2026. The company reported EPS of -$0.69, while revenue was $6.62 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Nyxoah EPS Results

Actual EPS
-$0.69
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Nyxoah Revenue Results

Actual Revenue
$6.62 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Nyxoah Q4 2025 Earnings FAQ

Nyxoah (NASDAQ:NYXH) reported earnings of -$0.69 per share for Q4 2025. The report was announced on Saturday, February 14, 2026.

Nyxoah reported revenue of $6.62 million for Q4 2025.

Nyxoah Earnings Headlines

Nyxoah (NASDAQ:NYXH) Upgraded at Wall Street Zen
November 10 at 2:18 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31188898
Nyxoah Earnings Call Highlights Growth and Guidance Reset
November 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/NYXH/pressreleases/8721779/nyxoah-earnings-call-highlights-growth-and-guidance-reset/
I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
November 12 at 1:00 AM  |  Behind the Markets (Ad)
Nyxoah (NYXH) Q3 2026 Earnings Call Transcript
November 6, 2026  |  fool.comhttps://www.fool.com/earnings/call-transcripts/2026/11/06/nyxoah-nyxh-q3-2026-earnings-call-transcript/
Nyxoah SA (NYXH) Q3 2026 Earnings Call Transcript
November 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4963541-nyxoah-sa-nyxh-q3-2026-earnings-call-transcript
Nyxoah Reports Third Quarter 2026 Financial and Operating Results
November 5, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/nyxoah-reports-third-quarter-2026-financial-and-operating-results-1036725181
See More Nyxoah Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nyxoah? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nyxoah and other key companies, straight to your email.

About Nyxoah

Nyxoah (NASDAQ:NYXH) S.A. is a medical technology company focused on developing and commercializing solutions for obstructive sleep apnea (OSA), a common sleep-related breathing disorder. The company is headquartered in Mont-Saint-Guibert, Belgium, and its shares trade on the Nasdaq under the symbol NYXH.

Nyxoah’s principal product is the Genio system, an implantable, rechargeable device designed to treat OSA through hypoglossal nerve stimulation. The system is intended to help maintain an open airway during sleep by stimulating the nerves that control the tongue and related upper-airway muscles. Unlike some traditional approaches, Genio is designed without an implanted breathing sensor or a stimulation lead placed in the chest.

The company has developed its business in European markets and has pursued commercialization in the United States. Genio has received regulatory clearances and approvals in various jurisdictions, including a CE mark in Europe and U.S. regulatory approval. Nyxoah is led by Chief Executive Officer Olivier Taelman, who has overseen the company’s efforts to advance and expand adoption of its sleep-apnea technology.

View Nyxoah Profile
Earnings Tools